Literature DB >> 29895708

A Peptidomic Approach to Characterize Peptides Involved in Cerebellar Cortex Development Leads to the Identification of the Neurotrophic Effects of Nociceptin.

Auriane Corbière1, Marie-Laure Walet-Balieu2, Philippe Chan2, Magali Basille-Dugay1, Julie Hardouin2, David Vaudry3,2,4.   

Abstract

The cerebellum is a brain structure involved in motor and cognitive functions. The development of the cerebellar cortex (the external part of the cerebellum) is under the control of numerous factors. Among these factors, neuropeptides including PACAP or somatostatin modulate the survival, migration and/or differentiation of cerebellar granule cells. Interestingly, such peptides contributing to cerebellar ontogenesis usually exhibit a specific transient expression profile with a low abundance at birth, a high expression level during the developmental processes, which take place within the first two postnatal weeks in rodents, and a gradual decline toward adulthood. Thus, to identify new peptides transiently expressed in the cerebellum during development, rat cerebella were sampled from birth to adulthood, and analyzed by a semi-quantitative peptidomic approach. A total of 33 peptides were found to be expressed in the cerebellum. Among these 33 peptides, 8 had a clear differential expression pattern during development, 4 of them i.e. cerebellin 2, nociceptin, somatostatin and VGF [353-372], exhibiting a high expression level during the first two postnatal weeks followed by a significative decrease at adulthood. A focus by a genomic approach on nociceptin, confirmed that its precursor mRNA is transiently expressed during the first week of life in granule neurons within the internal granule cell layer of the cerebellum, and showed that the nociceptin receptor is also actively expressed between P8 and P16 by the same neurons. Finally, functional studies revealed a new role for nociceptin, acting as a neurotrophic peptide able to promote the survival and differentiation of developing cerebellar granule neurons.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29895708      PMCID: PMC6126386          DOI: 10.1074/mcp.RA117.000184

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  53 in total

1.  Synapse-independent and synapse-dependent apoptosis of cerebellar granule cells in postnatal rabbits occur at two subsequent but partly overlapping developmental stages.

Authors:  L Lossi; S Mioletti; A Merighi
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

Review 2.  Proteases for processing proneuropeptides into peptide neurotransmitters and hormones.

Authors:  Vivian Hook; Lydiane Funkelstein; Douglas Lu; Steven Bark; Jill Wegrzyn; Shin-Rong Hwang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

3.  A Novel, Orally Bioavailable Nociceptin Receptor Antagonist, LY2940094, Reduces Ethanol Self-Administration and Ethanol Seeking in Animal Models.

Authors:  Linda M Rorick-Kehn; Roberto Ciccocioppo; Conrad J Wong; Jeffrey M Witkin; Maria A Martinez-Grau; Serena Stopponi; Benjamin L Adams; Jason S Katner; Kenneth W Perry; Miguel A Toledo; Nuria Diaz; Celia Lafuente; Alma Jiménez; Ana Benito; Concepción Pedregal; Friedbert Weiss; Michael A Statnick
Journal:  Alcohol Clin Exp Res       Date:  2016-04-16       Impact factor: 3.455

4.  PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis.

Authors:  D Vaudry; T F Pamantung; M Basille; C Rousselle; A Fournier; H Vaudry; J C Beauvillain; B J Gonzalez
Journal:  Eur J Neurosci       Date:  2002-05       Impact factor: 3.386

5.  Brain-derived neurotrophic factor (BDNF) can prevent apoptosis of rat cerebellar granule neurons in culture.

Authors:  T Kubo; T Nonomura; Y Enokido; H Hatanaka
Journal:  Brain Res Dev Brain Res       Date:  1995-04-18

6.  Spatio-temporal characterization of the pleiotrophinergic system in mouse cerebellum: evidence for its key role during ontogenesis.

Authors:  Magali Basille-Dugay; Magda M Hamza; Céline Tassery; Bénédicte Parent; Emilie Raoult; Magalie Bénard; Rita Raisman-Vozari; David Vaudry; Delphine C Burel
Journal:  Exp Neurol       Date:  2013-02-20       Impact factor: 5.330

7.  Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways.

Authors:  Melissa Ingram; Emily A L Wozniak; Christine Henzler; Lisa Duvick; Rendong Yang; Paul Bergmann; Robert Carson; Brennon O'Callaghan; Huda Y Zoghbi; Harry T Orr
Journal:  Neuron       Date:  2016-03-03       Impact factor: 17.173

8.  Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease.

Authors:  Ludovico Arcuri; Riccardo Viaro; Simone Bido; Francesco Longo; Mariangela Calcagno; Pierre-Olivier Fernagut; Nurulain T Zaveri; Girolamo Calò; Erwan Bezard; Michele Morari
Journal:  Neurobiol Dis       Date:  2016-01-22       Impact factor: 5.996

9.  Cortical-layer-specific effects of PACAP and tPA on interneuron migration during post-natal development of the cerebellum.

Authors:  Emilie Raoult; Magalie Bénard; Hitoshi Komuro; Alexis Lebon; Denis Vivien; Alain Fournier; Hubert Vaudry; David Vaudry; Ludovic Galas
Journal:  J Neurochem       Date:  2014-04-19       Impact factor: 5.372

10.  Distinct temporal expression of 5-HT(1A) and 5-HT(2A) receptors on cerebellar granule cells in mice.

Authors:  Marlies Oostland; M Renate Buijink; Guus M Teunisse; Lars von Oerthel; Marten P Smidt; Johannes A van Hooft
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

View more
  2 in total

Review 1.  Endogenous and exogenous opioid effects on oligodendrocyte biology and developmental brain myelination.

Authors:  Brandon Velasco; Esraa Mohamed; Carmen Sato-Bigbee
Journal:  Neurotoxicol Teratol       Date:  2021-06-12       Impact factor: 4.071

Review 2.  Strategies for the Identification of Bioactive Neuropeptides in Vertebrates.

Authors:  Auriane Corbière; Hubert Vaudry; Philippe Chan; Marie-Laure Walet-Balieu; Thierry Lecroq; Arnaud Lefebvre; Charles Pineau; David Vaudry
Journal:  Front Neurosci       Date:  2019-09-18       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.